{
  "id": "NGN-CLZ-300-206-R2",
  "version": "2.0.0",
  "label": "SIADH Management",
  "type": "clozeDropdown",
  "scoring": {
    "type": "dichotomous",
    "match": "exact"
  },
  "notes": "Updated to 2026 Specifications: SBAR, military time, rationales, clinical pearls.",
  "metadata": {
    "topic": "Endocrine Disorders",
    "subtopic": "SIADH Management",
    "setting": "Medical-Surgical Unit",
    "difficulty": 4,
    "cjmmStep": "Generate Solutions"
  },
  "stem": "**SITUATION:** A 68-year-old client with small cell lung cancer is admitted at 1400 with increasing confusion, headache, and nausea. \n\n**BACKGROUND:** The client has a history of small cell lung cancer and is receiving chemotherapy. The client's family reports a recent decline in mental status.\n\n**ASSESSMENT:** The nurse assesses the client and notes lethargy and disorientation to time and place. Vital signs: BP 140/90 mmHg, HR 92 bpm, RR 20, SpO2 96% on room air, Temp 37.2°C (99°F). Laboratory results show a serum sodium of 118 mEq/L, serum osmolality of 255 mOsm/kg, urine sodium of 55 mEq/L, and urine osmolality of 490 mOsm/kg. The provider diagnoses Syndrome of Inappropriate Antidiuretic Hormone (SIADH).\n\n**RECOMMENDATION:** The nurse reviews the new orders and plans the client's care. The nurse's priority action is to **[Blank 1]**. To correct the severe hyponatremia, the nurse will prepare to administer **[Blank 2]**. A key ongoing intervention will be to implement **[Blank 3]**. The nurse must vigilantly monitor the client's **[Blank 4]** during treatment.",
  "blanks": [
    {
      "id": "blank1",
      "options": [
        "Initiate seizure precautions",
        "Encourage increased oral fluid intake",
        "Administer a bolus of 0.9% sodium chloride",
        "Insert an indwelling urinary catheter"
      ]
    },
    {
      "id": "blank2",
      "options": [
        "3% hypertonic saline infusion",
        "0.45% sodium chloride infusion",
        "Furosemide intravenously",
        "Dextrose 5% in water (D5W)"
      ]
    },
    {
      "id": "blank3",
      "options": [
        "A strict fluid restriction",
        "A low-sodium diet",
        "Administration of desmopressin",
        "Hourly ambulation"
      ]
    },
    {
      "id": "blank4",
      "options": [
        "Neurological status",
        "Hourly urine output",
        "Serum potassium levels",
        "Peripheral edema"
      ]
    }
  ],
  "correctResponse": {
    "blank1": "Initiate seizure precautions",
    "blank2": "3% hypertonic saline infusion",
    "blank3": "A strict fluid restriction",
    "blank4": "Neurological status"
  },
  "answerBreakdown": {
    "blank1": {
      "Initiate seizure precautions": "Correct. A serum sodium level below 120 mEq/L, especially with neurological symptoms like confusion and lethargy, places the client at high risk for seizures due to cerebral edema. This is a critical safety intervention. **Rationale:** Hyponatremia causes fluid to shift into brain cells, leading to cerebral edema and increased intracranial pressure, increasing the risk of seizures. **Clinical Pearl:** Always prioritize safety when dealing with electrolyte imbalances. Seizure precautions include padded side rails, suction equipment at the bedside, and close observation.",
      "Encourage increased oral fluid intake": "Incorrect. In SIADH, the body retains excess free water, causing dilutional hyponatremia. Encouraging fluid intake would worsen the fluid overload and further lower the serum sodium level. **Rationale:** The pathophysiology of SIADH involves excessive ADH secretion, leading to water retention and dilutional hyponatremia. Increasing fluid intake exacerbates this process. **Clinical Pearl:** Fluid restriction is a cornerstone of SIADH management.",
      "Administer a bolus of 0.9% sodium chloride": "Incorrect. While isotonic, 0.9% NaCl would not effectively raise the serum sodium in a client with SIADH. The body would retain the water from the solution and excrete the sodium, potentially worsening the hyponatremia. **Rationale:** Isotonic saline does not provide a sufficient sodium concentration to correct severe hyponatremia in SIADH. The excess water retention will dilute the sodium further. **Clinical Pearl:** Hypertonic saline is required to effectively raise serum sodium levels in severe, symptomatic hyponatremia.",
      "Insert an indwelling urinary catheter": "Incorrect. While monitoring urine output is important, it is not the immediate priority. The client's safety from potential seizures takes precedence over obtaining precise output measurements at this moment. **Rationale:** While accurate I&O is important, preventing neurological complications is the priority. **Clinical Pearl:** Prioritize interventions based on the ABCs (Airway, Breathing, Circulation) and immediate safety concerns."
    },
    "blank2": {
      "3% hypertonic saline infusion": "Correct. For severe, symptomatic hyponatremia (Na < 120 mEq/L with neurological changes), a slow infusion of hypertonic saline is indicated. This solution has a higher concentration of sodium than the blood, helping to pull water out of the swollen brain cells and slowly raise the serum sodium level. **Rationale:** Hypertonic saline increases the serum osmolality, drawing fluid out of the intracellular space and into the vascular space, thereby increasing serum sodium concentration. **Clinical Pearl:** Hypertonic saline must be administered slowly and carefully to avoid overly rapid correction of sodium, which can lead to osmotic demyelination syndrome.",
      "0.45% sodium chloride infusion": "Incorrect. This is a hypotonic solution. Administering it would add more free water to the system, further diluting the serum sodium and exacerbating cerebral edema, which is extremely dangerous. **Rationale:** Hypotonic solutions decrease serum osmolality, causing fluid to shift into cells, worsening cerebral edema. **Clinical Pearl:** Never administer hypotonic solutions to patients with hyponatremia and neurological symptoms.",
      "Furosemide intravenously": "Incorrect. While a loop diuretic like furosemide may be used in SIADH management, it is typically administered along with hypertonic saline to promote the excretion of free water. It is not the primary intervention to correct the critically low sodium level itself and can worsen hyponatremia if given alone. **Rationale:** Furosemide promotes water excretion but can also lead to further sodium loss if not carefully managed. It is often used in conjunction with hypertonic saline to prevent fluid overload. **Clinical Pearl:** Diuretics should be used cautiously in SIADH and only under close monitoring of electrolytes and fluid balance.",
      "Dextrose 5% in water (D5W)": "Incorrect. D5W is an isotonic solution in the bag but becomes hypotonic in the body as the dextrose is metabolized, leaving only free water. This is strictly contraindicated as it would rapidly and severely worsen the hyponatremia. **Rationale:** D5W provides free water, which will further dilute the serum sodium concentration. **Clinical Pearl:** Avoid D5W in patients with hyponatremia."
    },
    "blank3": {
      "A strict fluid restriction": "Correct. This is a cornerstone of SIADH management. Limiting fluid intake (e.g., 800-1000 mL/day) prevents further dilution of serum sodium and allows the kidneys to excrete excess water, gradually correcting the imbalance. **Rationale:** Fluid restriction reduces the amount of free water available for retention, allowing the kidneys to excrete excess water and increase serum sodium concentration. **Clinical Pearl:** Consistent and accurate monitoring of fluid intake is crucial for the success of fluid restriction.",
      "A low-sodium diet": "Incorrect. The client's problem is an excess of water, not an excess of sodium. A sodium-restricted diet is inappropriate and could hinder recovery. In some cases of chronic SIADH, salt tablets may even be prescribed along with fluid restriction. **Rationale:** The primary issue in SIADH is water retention, not sodium excess. Restricting sodium intake is not beneficial and can be harmful. **Clinical Pearl:** Sodium intake is usually not restricted in SIADH; in some cases, it may even be increased.",
      "Administration of desmopressin": "Incorrect. Desmopressin (DDAVP) is a synthetic form of antidiuretic hormone (ADH). Since SIADH is a state of excessive ADH, giving more would worsen the condition significantly. **Rationale:** Desmopressin increases water reabsorption, which is the opposite of what is needed in SIADH. **Clinical Pearl:** Desmopressin is contraindicated in SIADH.",
      "Hourly ambulation": "Incorrect. While mobility is generally encouraged, this client is lethargic, confused, and at high risk for seizures. Ambulation is not a safe or priority intervention at this time. **Rationale:** The client's neurological status and risk for seizures make ambulation unsafe at this time. **Clinical Pearl:** Prioritize safety and address immediate risks before implementing routine interventions."
    },
    "blank4": {
      "Neurological status": "Correct. The most significant risks associated with severe hyponatremia are neurological (cerebral edema, seizures, coma). Furthermore, overly rapid correction of sodium can lead to a devastating neurological condition called osmotic demyelination syndrome. Therefore, frequent and careful monitoring of the client's level of consciousness, orientation, and motor function is the highest monitoring priority. **Rationale:** Neurological changes are the most immediate and life-threatening complications of hyponatremia and its treatment. **Clinical Pearl:** Frequent neurological assessments are essential to detect early signs of cerebral edema or osmotic demyelination syndrome.",
      "Hourly urine output": "Incorrect. Monitoring intake and output is essential for managing fluid balance, but changes in neurological status are a more direct and immediate indicator of the life-threatening complications of both the condition and its treatment. **Rationale:** While I&O is important, neurological status provides more immediate information about the client's condition. **Clinical Pearl:** Neurological assessments should be prioritized over routine I&O monitoring in this situation.",
      "Serum potassium levels": "Incorrect. While all electrolytes are important, the critical imbalance in SIADH is sodium and water. Potassium is not the primary electrolyte of concern and monitoring it is not the highest priority. **Rationale:** Sodium is the primary electrolyte of concern in SIADH. **Clinical Pearl:** Focus on the electrolyte imbalance that is directly related to the patient's condition.",
      "Peripheral edema": "Incorrect. SIADH is characterized by euvolemic hyponatremia, meaning there is fluid retention but not typically significant peripheral edema (pitting edema). Therefore, monitoring for this finding is not a sensitive or priority indicator of the client's fluid status or response to treatment. **Rationale:** SIADH typically presents with euvolemia, not hypervolemia with peripheral edema. **Clinical Pearl:** SIADH is characterized by dilutional hyponatremia without significant edema."
    }
  },
  "sentinelStatus": "healed_v2026_v8"
}